Expression profiling of genes regulated by TGF-beta: Differential regulation in normal and tumour cells

January 2007
BMC Genomics;2007, Vol. 8, p98
Academic Journal
No abstract available.


Related Articles

  • Autocrine growth inhibition by transforming growth factor beta-1 (TGFbeta-1) in human neuroendocrine tumour cells. Wimmel A; Wiedenmann B; Rosewicz S // Gut;Sep2003, Vol. 52 Issue 9, p1308 

    BACKGROUND: and aim: The role of transforming growth factor beta-1 (TGFbeta-1) in neuroendocrine tumour biology is currently unknown. We therefore examined the expression and biological significance of TGFbeta signalling components in neuroendocrine tumours (NETs) of the gastroenteropancreatic...

  • The Somatostatin Analogue Octreotide Inhibits Growth of Small Intestine Neuroendocrine Tumour Cells. Su-Chen Li; Martijn, Cécile; Tao Cui; Essaghir, Ahmed; Luque, Raúl M.; Demoulin, Jean-Baptiste; Castaño, Justo P.; Öberg, Kjell; Giandomenico, Valeria; López, Miguel // PLoS ONE;Oct2012, Vol. 7 Issue 10, Special section p1 

    Octreotide is a widely used synthetic somatostatin analogue that significantly improves the management of neuroendocrine tumours (NETs). Octreotide acts through somatostatin receptors (SSTRs). However, the molecular mechanisms leading to successful disease control or symptom management,...

  • RUNX3 expression in primary and metastatic pancreatic cancer. Li J; Kleeff J; Guweidhi A; Esposito I; Berberat P O; Giese T; B''chler M W; Friess H // Journal of Clinical Pathology;Mar2004, Vol. 57 Issue 3, p294 

    AIM: Runx transcription factors are important regulators of lineage specific gene expression, cell proliferation, and differentiation. Runx3 expression is lost in a high proportion of gastric cancers, suggesting a tumour suppressive role in this malignancy. This study investigates the expression...

  • E-Cadherin and EpCAM expression by NSCLC tumour cells associate with normal fibroblast activation through a pathway initiated by integrin αvβ6 and maintained through TGFβ signalling. Eberlein, C; Rooney, C; Ross, S J; Farren, M; Weir, H M; Barry, S T // Oncogene;2/5/2015, Vol. 34 Issue 6, p704 

    Fibroblasts in the tumour stroma (cancer-associated fibroblasts) influence tumour progression and response to therapeutics; little is known about the mechanisms through which the tumour cell co-opts a normal fibroblast. To study the activation of fibroblasts by tumour cells, a panel of non-small...

  • MicroRNA-590-5p regulates proliferation and invasion in human hepatocellular carcinoma cells by targeting TGF-β RII. Jiang, Xiaofeng; Xiang, Guangyang; Wang, Yezeng; Zhang, Lei; Yang, Xuewei; Cao, Liangqi; Peng, Heping; Xue, Ping; Chen, De // Molecules & Cells (Springer Science & Business Media B.V.);Jun2012, Vol. 33 Issue 6, p545 

    MicroRNAs (miRNAs) are regulatory small non-coding RNAs that can regulate gene expression by binding to gene elements, such as the gene promotor 5′UTR, mainly in the 3′UTR of mRNA. One miRNA targets many mRNAs, which can be regulated by many miRNAs, leading to a complex metabolic...

  • Study of differential effects of TGF-beta3/BMP2 on chondrogenesis in MSC cells by gene microarray data analysis. Sang, Yunxia; Zang, Weidong; Yan, Yan; Liu, Yong; Fu, Qiang; Wang, Kang; Chen, Yantian; Qi, Nianmin // Molecular & Cellular Biochemistry;Jan2014, Vol. 385 Issue 1/2, p191 

    In order to explore the differential effects of TGF-beta3 and BMP2 on chondrogenesis in mesenchymal stem cells (MSCs), the gene expression profiles of MSC treated with TGF-beta3 and BMP2 were subjected to systematic analysis on the gene and functional level. The gene expression profiles of MSCs...

  • Transcriptional activation of transforming growth factor-β1 in mesangial cell culture by high glucose concentration. Hoffman, Brenda B.; Sharma, Kumar; Yanqing Zhu; Ziyadeh, Fuad N. // Kidney International;Oct1998, Vol. 54 Issue 4, p1107 

    Examines the mechanisms of regulation of transforming growth factor (TGF)-Beta1 expression by high glucose in kidney cells. Role of TGF-Beta in the pathogenesis of diabetic nephropathy; Increase in TGF-Beta bioactivity in cell culture medium; Effect of glucose on the stimulation of TGF-Beta...

  • TGF-beta1 reduces Wilms' tumor suppressor gene expression in podocytes. Sakairi, Toru; Abe, Yoshifusa; Kopp, Jeffrey B. // Nephrology Dialysis Transplantation;Sep2011, Vol. 26 Issue 9, p2746 

    Background. Wilms' tumor suppressor gene (WT1) is essential for normal podocyte function, and transforming growth factor (TGF)-beta contributes to focal segmental glomerulosclerosis (FSGS). We aimed to address whether TGF-beta affects WT1 expression in podocytes.Methods. A human podocyte cell...

  • Integrated approaches to miRNAs target definition: time-series analysis in an osteosarcoma differentiative model. Grilli, A.; Sciandra, M.; Terracciano, M.; Picci, P.; Scotlandi, K. // BMC Medical Genomics;2015, Vol. 8 Issue 1, p1 

    Background: microRNAs (miRs) are small non-coding RNAs involved in the fine regulation of several cellular processes by inhibiting their target genes at post-transcriptional level. Osteosarcoma (OS) is a tumor thought to be related to a molecular blockade of the normal process of osteoblast...

  • A Web-Based Data Warehouse on Gene Expression in Human Malignant Melanoma. Györffy, Balazs; Lage, Hermann // Journal of Investigative Dermatology;Feb2007, Vol. 127 Issue 2, p394 

    The identification of melanoma-specific dysregulated genes could identify new molecular markers. By applying bioinformatic tools for screening of biomedical databases, a melanoma-specific gene expression profile “data warehouse” was constructed. Utilizable data sets of global gene...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics